Stock listing
BIAF Stock Price, News, Filings & Events — Bioaffinity Technologies, Inc.
Selected listing: BIAF · NASDAQ · USD · US
This page tracks Bioaffinity Technologies, Inc.'s BIAF:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIAF:NASDAQ. BIAF:NASDAQ is the stock-level entry point for investors researching Bioaffinity Technologies, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bioaffinity Technologies, Inc. (Ticker: BIAF) is a public company operating in the American market with a market capitalization of approximately $4.82 million. The company focuses on developing innovative technologies in the healthcare sector. Its efforts aim to improve diagnostic and therapeutic solutions for various medical conditions.
- Ticker
- BIAF:NASDAQ
- Asset type
- Stock
- Market cap
- $3.9M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Bioaffinity Technologies, Inc. BIAF:NASDAQ stock context
This page tracks Bioaffinity Technologies, Inc.'s BIAF:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIAF:NASDAQ. BIAF:NASDAQ is the stock-level entry point for investors researching Bioaffinity Technologies, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bioaffinity Technologies, Inc. (Ticker: BIAF) is a public company operating in the American market with a market capitalization of approximately $4.82 million. The company focuses on developing innovative technologies in the healthcare sector. Its efforts aim to improve diagnostic and therapeutic solutions for various medical conditions.
Latest news from Bioaffinity Technologies, Inc.
BioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors
September 1, 2026
BioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026
August 20, 2026
bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026
August 20, 2026
WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
August 13, 2026
BioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
August 13, 2026
Bioaffinity Technologies, Inc. earnings calls
Research Bioaffinity Technologies, Inc.
Bioaffinity Technologies, Inc. investor report
Review AI stock analysis and investor report context for BIAF:NASDAQ.
Bioaffinity Technologies, Inc. company profile
View the public company page for Bioaffinity Technologies, Inc. on 6ix.
Bioaffinity Technologies, Inc. news
Read company news and market updates connected to Bioaffinity Technologies, Inc..
Bioaffinity Technologies, Inc. investor events
Find investor webinars, events, and replay context for Bioaffinity Technologies, Inc..